| HBS Case Collection
(Revised from original 2005 version)
WuXi Pharmatech has gone from zero to $21 million in sales in three years. The company must decide its growth strategy and how best to finance and organize for rapid growth.
Keywords: Growth Management;
Problems and Challenges;
Hamermesh, Richard G., and Simin Zhou. "WuXi PharmaTech." Harvard Business School Case 806-003, June 2006. (Revised from original September 2005 version.)